Harpoon Therapeutics, Inc. Contracts & Agreements

56 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Development and Option Agreement between the Registrant and AbbVie Biotechnology Ltd., dated as of November 20, 2019
Development Agreements
Harpoon Therapeutics, Inc.
Biotechnology
DE
2020
Agreement and Plan of Merger, by and among Merck Sharp & Dohme LLC, Harpoon Therapeutics, Inc., and Hawaii Merger Sub, Inc., dated January 7, 2024
Merger Agreements
Harpoon Therapeutics, Inc.
2024
Form of Retention Bonus Agreement, dated November 26, 2023
Bonus & Incentive Agreements
Harpoon Therapeutics, Inc.
2023
Form of Restricted Stock Unit Award Notice and Agreement, dated November 26, 2023
Stock Agreements
Harpoon Therapeutics, Inc.
2023
Form of October 2023 Warrant to Purchase Common Stock or Pre-Funded Warrants
Warrant Agreements
Harpoon Therapeutics, Inc.
2023
Form of October 2023 Pre-Funded Warrant
Warrant Agreements
Harpoon Therapeutics, Inc.
2023
Form of Securities Purchase Agreement
Purchase Agreements
Harpoon Therapeutics, Inc.
2023
Form of Registration Rights Agreement
Registration Rights Agreements
Harpoon Therapeutics, Inc.
2023
Form of Common Stock Purchase Warrant
Warrant Agreements
Harpoon Therapeutics, Inc.
2023
Securities Purchase Agreement, dated March 22, 2023, by and among the Company and the Purchasers
Purchase Agreements
Harpoon Therapeutics, Inc.
Biotechnology
NY
2023
Registration Rights Agreement, dated March 22, 2023, by and among the Company and the Purchasers
Registration Rights Agreements
Harpoon Therapeutics, Inc.
2023
Harpoon Therapeutics, Inc. 2019 Equity Incentive Plan and related form agreements
Bonus & Incentive Agreements
Harpoon Therapeutics, Inc.
2022
Harpoon Therapeutics, Inc. 2022 Inducement Plan, Form of Stock Option Grant Notice, Option Agreement, Form of Restricted Stock Grant Notice and Restricted Stock Unit Award...
Stock Agreements
Harpoon Therapeutics, Inc.
Biotechnology
DE
2022
Employment Offer Letter by and between Julie Eastland and the Registrant dated as of October 25, 2021
Employment Agreements
Harpoon Therapeutics, Inc.
Biotechnology
CA
2022
Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Harpoon Therapeutics, Inc.
2022
Transition and Retirement Agreement by and between Gerald McMahon and the Registrant, dated as of October 25, 2021
Retirement Agreements
Harpoon Therapeutics, Inc.
2022
Harpoon Therapeutics, Inc. South San Francisco, CA
Harpoon Therapeutics, Inc.
Biotechnology
CA
2022
Amendment No. 1 to Amended and Restated Discovery Collaboration and License Agreement by and between the Registrant and AbbVie, Inc., dated as of August 16, 2021
Collaboration Agreements
Harpoon Therapeutics, Inc.
2021
Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Harpoon Therapeutics, Inc.
2021
Underwriting Agreement, dated January 6, 2021, by and among the Company, SVB Leerink LLC and Piper Sandler & Co., as the Representatives of the several underwriters named therein
Underwriting Agreements
Harpoon Therapeutics, Inc.
2021
First Amendment to the Development and Option Agreement between the Registrant and AbbVie Biotechnology Ltd., dated as of April 21, 2020
Development Agreements
Harpoon Therapeutics, Inc.
Biotechnology
2020
Side Letter Amendment to Development and Option Agreement between the Registrant and AbbVie Biotechnology Ltd., dated April 15, 2020
Development Agreements
Harpoon Therapeutics, Inc.
Biotechnology
2020
Description of Registrants securities registered pursuant to Section 12 of the Securities Exchange Act of 1934
Harpoon Therapeutics, Inc.
Biotechnology
2020
Second Amended and Restated Assignment and License Agreement between the Registrant and Werewolf Therapeutics, Inc., dated as of December 20, 2019
License Agreements
Harpoon Therapeutics, Inc.
2020
Fifth Amended and Restated Consulting Agreement by and between Patrick Baeuerle and the Registrant, dated as of March 3, 2020
Consulting Agreements
Harpoon Therapeutics, Inc.
2020
Amended and Restated Discovery Collaboration and License Agreement between the Registrant and AbbVie Biotechnology Ltd., dated as of November 20, 2019
Collaboration Agreements
Harpoon Therapeutics, Inc.
Biotechnology
DE
2020
First Amendment to the Discovery Collaboration and License Agreement between the Registrant and AbbVie Biotechnology Ltd., dated as of April 3, 2019
Collaboration Agreements
Harpoon Therapeutics, Inc.
2019
Form of Underwriting Agreement
Underwriting Agreements
Harpoon Therapeutics, Inc.
2019
Asset Transfer Agreement by and between Maverick Therapeutics, Inc. and the Registrant, dated as of December 30, 2016, as amended
Harpoon Therapeutics, Inc.
2019
Form of Common Stock Certificate
Stock Agreements
Harpoon Therapeutics, Inc.
2019
2019 Equity Incentive Plan and forms of grant notice, stock option and restricted stock unit award agreements and notice of exercise thereunder
Bonus & Incentive Agreements
Harpoon Therapeutics, Inc.
2019
2019 Employee Stock Purchase Plan
Stock Agreements
Harpoon Therapeutics, Inc.
Biotechnology
2019
Non-Employee Director Compensation Policy
Compensation Agreements
Harpoon Therapeutics, Inc.
Biotechnology
2019
Amendment to CHEF1 Collaboration and License Agreement and Development and Manufacturing Services Agreement between Registrant and AGC Biologics, Inc. (formerly known as CMC ICOS...
Collaboration Agreements
Harpoon Therapeutics, Inc.
Biotechnology
2019
Form of Indemnity Agreement, by and between the Registrant and its directors and executive officers
Harpoon Therapeutics, Inc.
Biotechnology
DE
2019
Employment Offer Letter by and between Georgia Erbez and the Registrant, dated October 19, 2018
Employment Agreements
Harpoon Therapeutics, Inc.
Biotechnology
2019
Asset Transfer Agreement by and between Maverick Therapeutics, Inc. and the Registrant, dated as of December 30, 2016, as amended
Harpoon Therapeutics, Inc.
2018
Amended and Restated Investors Rights Agreement, dated as of November 9, 2018, by and among the Registrant and certain of its stockholders
Investor Rights Agreements
Harpoon Therapeutics, Inc.
Biotechnology
DE
2018
Warrant to Purchase Common Stock issued on July 13, 2016 to Danforth Advisors, LLC
Warrant Agreements
Harpoon Therapeutics, Inc.
2018
Form of Warrant to Purchase Common Stock issued to entities affiliated with MPM Capital, Inc. on March 24, 2015, July 23, 2015, August 17, 2015 and December 16, 2015 in connection...
Warrant Agreements
Harpoon Therapeutics, Inc.
Biotechnology
CA
2018
Form of Warrant to Purchase Common Stock issued to entities affiliated with MPM Capital, Inc. and UBS Oncology Impact Fund L.P. on November 1, 2016 and January 10, 2017 in...
Stock Agreements
Harpoon Therapeutics, Inc.
2018
2015 Equity Incentive Plan and forms of grant notice, stock option and restricted stock unit award agreements and notice of exercise thereunder
Bonus & Incentive Agreements
Harpoon Therapeutics, Inc.
2018
Employment Offer Letter by and between Gerald McMahon and the Registrant, dated December 10, 2016
Employment Agreements
Harpoon Therapeutics, Inc.
Biotechnology
CA
2018
Employment Offer Letter by and between Holger Wesche and the Registrant, dated March 17, 2015, as amended
Employment Agreements
Harpoon Therapeutics, Inc.
2018
Employment Offer Letter by and between Natalie Sacks and the Registrant, dated September 13, 2018
Employment Agreements
Harpoon Therapeutics, Inc.
2018
Consulting Agreement between the Company and William Picht, Jr., dated September 12, 2018
Consulting Agreements
Harpoon Therapeutics, Inc.
Biotechnology
CA
2018
Third Amended and Restated Consulting Agreement dated as of February 1, 2017, by and between the Registrant and Patrick Baeuerle, as amended
Consulting Agreements
Harpoon Therapeutics, Inc.
Biotechnology
MA
2018
Discovery Collaboration and License Agreement between the Registrant and AbbVie Biotechnology Ltd., dated as of October 10, 2017
Collaboration Agreements
Harpoon Therapeutics, Inc.
2018
License Agreement between the Registrant and TCR2 Therapeutics, Inc., dated June 21, 2017
License Agreements
Harpoon Therapeutics, Inc.
2018
Royalty Transfer Agreement by and between the Registrant, MPM Oncology Charitable Foundation, Inc. and the UBS Optimus Foundation, dated December 1, 2016, as amended
Harpoon Therapeutics, Inc.
Biotechnology
MA
2018
First Amended and Restated Assignment and License Agreement between Werewolf Therapeutics, Inc. and the Registrant, dated as of October 19, 2018
License Agreements
Harpoon Therapeutics, Inc.
Biotechnology
CA
2018
CHEF1 Collaboration and License Agreement between the Registrant and CMC ICOS Biologics, Inc., dated October 26, 2015
Collaboration Agreements
Harpoon Therapeutics, Inc.
Biotechnology
DE
2018
Development and Manufacturing Services Agreement between the Registrant and CMC ICOS Biologics, Inc., dated July 5, 2016
Development Agreements
Harpoon Therapeutics, Inc.
2018
Sublease between Tizona Therapeutics, Inc. and the Registrant, dated as of February 6, 2017
Lease Agreements
Harpoon Therapeutics, Inc.
2018
Lease by and between AP3-SF1 4000 Shoreline, LLC and Tizona Therapeutics, Inc., dated as of December 21, 2015, as amended
Lease Agreements
Harpoon Therapeutics, Inc.
Biotechnology
CA
2018
Lease by and between HCP Oyster Point III LLC and the Registrant, dated as of July 27, 2018
Lease Agreements
Harpoon Therapeutics, Inc.
Biotechnology
CA
2018